Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
| HCPC | Q0247 |
| Short Description | Sotrovimab |
| Long Description | Injection, sotrovimab, 500 mg |
| Pricing indicator | 54 |
| Coverage code | C |
| ASC payment group code | |
| BETOS2 code | O1G |
| Action code | N |
| Type of service | V |
| Effective date | 2021-05-26 |
| Date Added | 2021-05-26 |
Drug Details
-
Sotrovimab injection is used to treat COVID-19 infection in certain non-hospitalized adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) and who have mild to moderate COVID-19 symptoms. It is used in people who have certain medical conditions that make them at higher risk for developing severe COVID-19 symptoms, including the need to be hospitalized from COVID-19 infection or death. Sotrovimab is in a class called monoclonal antibodies. It works by blocking the action of a certain natural substance in the body in order to stop the spread of the virus.